Are You Prepared for the 2024 Medicare Advantage Final Rule Changes?

CMS has released the 2024 Medicare Advantage and Part D Final Rule. While not all of the significant changes from the proposed rule have been addressed in this initial rule, those that are will still have far-reaching effects on MA plans, impacting areas including Star Ratings, access to care, health equity, and beneficiary protections.

Cureatr and Rex Wallace Consulting experts, along with Dr. Robert Mirsky and Jenn Wirick, PharmD, BCACP, BCGP, are coming together to dive into some of the most noteworthy provisions that have and have not been addressed and what all of this means for your organization. 

Topics You Won’t Want to Miss:

• Transition to the Health Equity Index (HEI) reward for 2027 Star Ratings/calendar year 2025
• Drop in patient experience/complaints and access measures from 4x to 2x weight for CY 2024 
• Translation and accessible format requirements for marketing and communication materials
• Expectations for the "second" final rule 

Our Panelists:

	Tram Thai, PharmD, BCACP, AE-C Executive Director of Clinical Excellence, Cureatr
	Jessica Muratore Senior Consultant at Rex Wallace Consulting, LLC
	Dr. Robert Mirsky President at Resilient HealthOutcomes Advisors, LLC
	Jennifer Wirick, PharmD, BCACP, BCGP Innovative Healthcare Leader